Intra-Cellular Therapies Inc.

NAS: ITCI

GO

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders
/marketstate/country/us
Intra-Cellular Therapies Inc.

Market open

ITCI
/zigman2/quotes/209441868/composite

$

51.21

Change

-0.29 -0.56%

Volume

Volume 118,235

Aug 18, 2022, 10:43 a.m.

Real time quotes

/zigman2/quotes/209441868/composite

Previous close

$ 51.50

$ 51.21

Change

-0.29 -0.56%

Day low

Day high

$50.86

$52.17

Open
Open: 51.76

52 week low

52 week high

$28.45

$66.00

Open

Market cap

$4.86B

Average volume

755,406

P/E ratio

N/A

Rev. per Employee

$270,416

EPS

-3.69

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/itci

MarketWatch News on ITCI

  1. Intra-Cellular Therapies started at buy with $74 stock price target at Mizuho

    7:06 a.m. July 7, 2022

    - Tomi Kilgore

  2. Intra-Cellular Therapies started at buy with $75 stock price target at UBS

    10:52 a.m. June 14, 2022

    - Tomi Kilgore

  4. The FDA Is About to Make Some Major Drug Decisions

    2:51 p.m. Oct. 16, 2021

    - Barron's Online

  6. Intra-Cellular Therapies downgraded to neutral from overweight at J.P. Morgan

    8:54 a.m. Jan. 31, 2020

    - Tomi Kilgore

  7. Intra-Cellular Therapies stock price target raised to $65 vs. $29 at Canaccord

    11:48 a.m. Dec. 24, 2019

    - Ciara Linnane

  8. Intra-Cellular Therapies reiterated as buy at Canaccord

    11:48 a.m. Dec. 24, 2019

    - Ciara Linnane

  11. Intra-Cellular Therapies gets FDA approval for schizophrenia treatment

    8:14 a.m. Dec. 23, 2019

    - Ciara Linnane

  12. Intra-Cellular Therapies stock soars 42% premarket

    8:14 a.m. Dec. 23, 2019

    - Ciara Linnane

  14. Intra-Cellular Therapies shares slide 7% after resuming trade following halt.

    7:36 a.m. July 8, 2019

    - Ciara Linnane

  16. Intra-Cellular announces positive results in late-stage trial of treatment for bipolar depression

    7:05 a.m. July 8, 2019

    - Ciara Linnane

  17. Intra-Cellular Therapies and Sol-Gel Technologies halted for news pending

    6:58 a.m. July 8, 2019

    - Ciara Linnane

  20. Intra-Cellular Therapies started at overweight with $25 stock price target at J.P. Morgan

    8:59 a.m. Feb. 26, 2018

    - Tomi Kilgore

  21. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/itci

Other News on ITCI

  1. Top 5 2nd Quarter Trades of WASATCH ADVISORS INC

    7:00 p.m. Aug. 12, 2022

    - GuruFocus.com

  4. 10-Q: INTRA-CELLULAR THERAPIES, INC.

    7:49 a.m. Aug. 9, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  6. Intra-Cellular Therapies Q2 2022 Earnings Preview

    2:22 p.m. Aug. 8, 2022

    - Seeking Alpha

  7. Notable earnings before Tuesday's open

    10:46 a.m. Aug. 8, 2022

    - Seeking Alpha

  10. Lisanti Capital Growth, LLC Buys 3, Sells 2 in 2nd Quarter

    9:00 a.m. Aug. 3, 2022

    - GuruFocus.com

  14. Axsome: Breaking Bearish Trend

    9:59 a.m. July 26, 2022

    - Seeking Alpha

  17. Intra-Cellular Therapies: A Dramatic Story

    3:24 a.m. June 18, 2022

    - Seeking Alpha

  19. Wasatch Core Growth Fund Q1 2022 Commentary

    10:56 a.m. May 25, 2022

    - Seeking Alpha

  20. Wasatch Small Cap Value Fund Q1 2022 Commentary

    10:26 a.m. May 25, 2022

    - Seeking Alpha

  21. Loading more headlines...
/news/pressrelease/company/us/itci

Press Releases on ITCI

  7. What Stocks To Buy This Week? 4 Biotech Stocks To Know

    11:20 a.m. May 15, 2022

    - StockMarket.com

  16. Intra-Cellular Therapies Inc. (ITCI): The Winning Streak Continues

    11:44 a.m. Feb. 16, 2022

    - Investor Brand Network

  19. Intra-Cellular Therapies Prices Public Offering of Common Stock

    11:05 p.m. Jan. 4, 2022

    - GlobeNewswire

  21. Loading more headlines...

Rates »

Mortgage Equity Savings Auto
Link to MarketWatch's Slice.